ATP6V1G2 and cardiovascular disorder: ATP6V1G2 is recognized as an up-regulated biomarker of ferroptosis48, and as far as available studies indicated that ATP6V1G2 operated mainly in cardiovascular system diseases such as myocardial infarction49, adriamycin-induced cardiotoxicity50 and dilated cardiomyopathy51.